Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQH2722 in Seasonal Allergic Rhinitis
NCT06760182Phase 2Completed
- Sponsor
- Chia Tai Tianqing
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of TQH2722 in seasonal allergic rhinitis (SAR), sponsored by Chia Tai Tianqing. Started Mar 2025; status: completed.
02
Drugs
TQH2722
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT06760182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06760182.